In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Dynavax Technologies Corp. (NASDAQ: DVAX) was $11.00 for the day, down -0.27% from the previous closing price of $11.03. In other words, the price has decreased by -$0.27 from its previous closing price. On the day, 3.18 million shares were traded. DVAX stock price reached its highest trading level at $11.09 during the session, while it also had its lowest trading level at $10.53.
Ratios:
Our analysis of DVAX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.33. For the most recent quarter (mrq), Quick Ratio is recorded 14.10 and its Current Ratio is at 15.20. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on February 01, 2024, initiated with a Neutral rating and assigned the stock a target price of $20.
On September 27, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 01 ’24 when Burgess Justin sold 20,526 shares for $12.78 per share. The transaction valued at 262,322 led to the insider holds 0 shares of the business.
Janssen Robert sold 1,500 shares of DVAX for $22,500 on Jan 04 ’24. The SVP and CMO now owns 49,925 shares after completing the transaction at $15.00 per share. On Jan 02 ’24, another insider, Novack David F, who serves as the President & COO of the company, sold 9,000 shares for $14.45 each. As a result, the insider received 130,050 and left with 3,187 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DVAX now has a Market Capitalization of 1443739008 and an Enterprise Value of 972370816. As of this moment, Dynavax’s Price-to-Earnings (P/E) ratio for their current fiscal year is 203.70, and their Forward P/E ratio for the next fiscal year is 26.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.10 while its Price-to-Book (P/B) ratio in mrq is 2.33. Its current Enterprise Value per Revenue stands at 4.118 whereas that against EBITDA is -58.16.
Stock Price History:
Over the past 52 weeks, DVAX has reached a high of $15.15, while it has fallen to a 52-week low of $10.48. The 50-Day Moving Average of the stock is -7.98%, while the 200-Day Moving Average is calculated to be -17.65%.
Shares Statistics:
DVAX traded an average of 2.06M shares per day over the past three months and 2539860 shares per day over the past ten days. A total of 130.89M shares are outstanding, with a floating share count of 130.44M. Insiders hold about 0.35% of the company’s shares, while institutions hold 100.94% stake in the company. Shares short for DVAX as of 1714435200 were 19622683 with a Short Ratio of 9.54, compared to 1711584000 on 17965866. Therefore, it implies a Short% of Shares Outstanding of 19622683 and a Short% of Float of 18.33.
